Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer
Información
- DOI:
- https://doi.org/10.1002/14651858.CD011964Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 diciembre 2015see what's new
- Tipo:
-
- Diagnostic
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres
- Copyright:
-
- Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
-
Guarantor of the review: SS, JD
-
Conceiving the idea: SS, CD, JD
-
Designing and coordinating the review: NR, CD, SS, JD
-
Designing search strategies: SB, NR, CD, SS, RN
-
Screening, data extraction, quality assessment: NR, RC, CD
-
Obtaining and screening data on unpublished studies: NR, RC
-
Data management of the review: NR
-
Analysis and interpretation of data: SM, KS, NR, SS, CD, JD
-
Writing the review: NR, CD, SS
-
Providing general advice on the review: RN, MB, SK, CD, SS, JD
-
Securing funding for the review: SS, CD, JD
Sources of support
Internal sources
-
None, Other.
External sources
-
National Institute for Health Research (HTA programme: 13/13/01), UK.
Declarations of interest
This review and participation of all authors in it has been funded as part of a programme of research (ROCkeTS ‐ Refining Ovarian Cancer Test Accuracy Scores).
Moji Balogun ‐ None known
Susan Bayliss ‐ None known
Rita Champaneria ‐ None known
Clare Davenport ‐ Received funding from the NIHR HTA to support this review in a methodological capacity.
Jon Deeks ‐ This work is a funded project, funded by the NIHR HTA Commissioning Board.
Sean Kehoe ‐ Recieved payment from Roche and Astra‐Zenica for lecturing expenses and Sanofi Pastuer paid expenses for attendance at EUROGIN meeting 2015.
Susan Mallett ‐ Co‐applicant on one funded government funded grant (mpMRI imaging) and one recently submitted grant (circulating DNA) for the diagnosis of ovarian cancer.
Richard Neal ‐ Holds, or has held grants from a number of bodies including: HTA, NIHR, NISCHR, Cancer Research Wales, Tenovus, Cancer Research UK, Department of Health, Prostate Cancer UK. Has received a fee for a lectures for Manitoba Cancer Care.
Nirmala Rai ‐ My participation in this review is funded by the NIHR grant listed.
Kym Snell ‐ My participation in this review is funded by the NIHR grant listed.
Sudha Sundar ‐ None known
Acknowledgements
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.
We thank Jo Morrison for clinical and editorial advice and Clare Jess for her contribution to the editorial process.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Jul 26 | Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women | Review | Clare Davenport, Nirmala Rai, Pawana Sharma, Jonathan J Deeks, Sarah Berhane, Sue Mallett, Pratyusha Saha, Rita Champaneria, Susan E Bayliss, Kym IE Snell, Sudha Sundar | |
| 2015 Dec 07 | Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer | Protocol | Nirmala Rai, Rita Champaneria, Kym Snell, Susan Mallett, Susan E Bayliss, Richard D Neal, Moji Balogun, Sean Kehoe, Jonathan J Deeks, Sudha Sundar, Clare Davenport | |
